Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Thyroidectomy, and Parathyroidectomy.

Aarti Mathur, M.D., FACS, is an experienced, fellowship-trained endocrine surgeon in the Johns Hopkins Division of Surgical Oncology and an associate professor of surgery at the Johns Hopkins University School of Medicine. Dr. Mathur sees patients at The Johns Hopkins Hospital in Baltimore and at Sibley Memorial Hospital in Washington, D.C. Dr. Mathur earned her medical degree at the University of Texas. She completed a general surgery residency at MedStar Georgetown University Hospital, followed by fellowships at the National Cancer Institute, where she studied immunotherapy and surgical oncology for several years, performed endocrine surgery research and cared for patients with advanced oncologic diseases. Dr. Mathur also completed a fellowship in endocrine surgery at the Johns Hopkins University School of Medicine. Dr. Mathur’s practice exclusively focuses on surgical management of benign and malignant diseases of the thyroid, parathyroid, adrenal glands and cervical lymph nodes. Her expertise includes thyroid surgery for nodules, goiters, Graves disease, thyroid cancer and minimally invasive parathyroidectomy, surgery for persistent or recurrent hyperparathyroidism and laparoscopic adrenalectomy. She believes in providing state of the art, patient-centered multi-disciplinary care for complex endocrine surgical issues. Dr. Mathur serves on multiple committees of major national societies including the American Association of Endocrine Surgeons, the American Thyroid Association, and the American College of Surgeons. As a surgeon-scientist, Dr. Mathur directs a research group, funded by the National Institutes of Health, that studies voice and swallowing outcomes after thyroidectomy in older adults. Her research also focuses on understanding the link between hyperparathyroidism and other health conditions including cognitive impairment, cardiovascular disease and post-transplant outcomes. Dr. Mathur has numerous prestigious national research awards and grants, and she has published over 50 peer reviewed articles, reviews and book chapters. She is frequently invited to present her research at national and international meetings. Dr. Mathur is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

David Litman is an Otolaryngologist in Cumberland, Maryland. Dr. Litman is rated as a Distinguished provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Thyroid Nodule, Gastrostomy, and Thyroidectomy. Dr. Litman is currently accepting new patients.

Joel Turner is a General Surgeon in Baltimore, Maryland. Dr. Turner is rated as a Distinguished provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Familial Isolated Hyperparathyroidism, and Hernia Surgery. Dr. Turner is currently accepting new patients.

Jon Russell is an Otolaryngologist in Columbia, Maryland. Dr. Russell is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Thyroid Nodule, Thyroidectomy, and Parathyroidectomy.

Otolaryngologist Vaninder “Vinny” K. Dhillon specializes in endocrine surgery, laryngology, otolaryngology, parathyroid diseases and surgery, swallowing disorders, thyroid diseases and surgery, and voice problems. She treats both children and adults. After earning her medical degree from Keck School of Medicine of the University of Southern California, Dr. Dhillon completed a residency in otolaryngology at Los Angeles County and University of Southern California Medical Center. Dr. Dhillon’s research interests include the role of voice outcomes in patients after thyroid and parathyroid surgery when there is concern for vocal fold weakness or paralysis, evaluation of the role of office-based treatment on vocal fold paralysis, as well as neurogenic recovery of vocal fold paralysis. Dr. Dhillon is also interested in treatments for neurogenic chronic cough, which is refractory to other medical intervention. Dr. Dhillon is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Laryngeal Nerve Damage, Spasmodic Dysphonia, Neurofibromatosis Type 2 (NF2), Thyroidectomy, and Parathyroidectomy.

Vikram Shenoy, M.D., practices endocrinology at Johns Hopkins Community Physicians Downtown Bethesda. He received his medical degree from University of Connecticut School of Medicine, and also completed his residency in endocrinology at Hospital of the University of Pennsylvania. He practices general endocrinology, including the treatment of thyroid disorders, diabetes, PCOS, pituitary and adrenal disorders, hypogonadism and osteoporosis. Dr. Shenoy is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Dr. Anatoliy Rudin is a distinguished endocrine surgeon and Assistant Professor in the Department of Surgery, Division of Surgical Oncology. With a specialization in the treatment of thyroid, parathyroid, and adrenal diseases, Dr. Rudin brings a wealth of experience and expertise to his practice. He completed his General Surgery residency at the Mayo Clinic in Rochester, MN, followed by an Endocrine Surgery Fellowship at the Cleveland Clinic in Cleveland, OH. Dr. Rudin's research interest is dedicated to improving surgical outcomes through the integration of emerging technologies, advanced imaging, and minimally invasive techniques. His contributions to the field are well-documented through multiple publications and book chapters. Additionally, he has extensive leadership experience and holds committee responsibilities with organizations, including the American Association of Endocrine Surgeons. In his clinical practice, Dr. Rudin provides comprehensive surgical evaluations for patients with endocrine disorders and cancer. He employs a variety of diagnostic techniques, including ultrasound, fine needle aspiration, cytology, and molecular testing, to ensure accurate diagnosis and assessment. Dr. Rudin is adept in the latest surgical techniques, including robotic surgery, and offers personalized treatment options for thyroid, parathyroid, and adrenal diseases. He is committed to a holistic approach to patient care, working closely with individuals to develop tailored treatment plans that address their unique needs. Currently, Dr. Rudin sees patients at the Johns Hopkins Howard County Medical Center. Dr. Rudin is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Cancer, Parathyroidectomy, and Thyroidectomy.

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Noriecel Mendoza, MD, specializes in endocrinology and is board-certified in endocrinology, diabetes, and metabolism by the American Board of Internal Medicine. She practices at UPMC Western Maryland Endocrinology. Dr. Mendoza received her medical degree from the University of Santo Tomas and completed her residency at Albert Einstein College of Medicine, followed by a fellowship at the University of Arizona College of Medicine. Dr. Mendoza is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Hyperparathyroidism, Hyperthyroidism, Thyroid Storm, and Type 2 Diabetes (T2D).

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Yinin Hu is a Surgical Oncologist and a General Surgeon in Cheverly, Maryland. Dr. Hu is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Thyroidectomy, and Gastrectomy. Dr. Hu is currently accepting new patients.

Nowreen Haq is an Endocrinologist in Annapolis,, Maryland. Dr. Haq is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Type 2 Diabetes (T2D), Hypothyroidism, Exogenous Cushing's syndrome, and Cushing's syndrome due to Adrenal Tumor.

Heranmaye Prasad is an Endocrinologist in Baltimore, Maryland. Dr. Prasad is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Hashimoto Thyroiditis, Hypothyroidism, Type 2 Diabetes (T2D), and Obesity in Children.

Emily Gammoh is an Endocrinologist in Cumberland, Maryland. Dr. Gammoh is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Osteitis Fibrosa, Parathyroid Hyperplasia, Familial Isolated Hyperparathyroidism, and Neonatal Severe Hyperparathyroidism.

Hillary Barnes is an Endocrinologist in Reisterstown, Maryland. Dr. Barnes has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Type 2 Diabetes (T2D), Osteoporosis, Postmenopausal Osteoporosis, and Diabetic Nephropathy.

Marisha Newton is an Endocrinologist in Baltimore, Maryland. Dr. Newton is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. Her top areas of expertise are Idiopathic Hypercalciuria, Hypercalcemia, Familial Hypocalciuric Hypercalcemia Type 1, and Milk-Alkali Syndrome.

Artit Silpasuvan is an Endocrinologist in Baltimore, Maryland. Dr. Silpasuvan is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Neonatal Severe Hyperparathyroidism, and Osteitis Fibrosa.